The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALKAMI COM 01644J108 351,148,169 19,379,038 SH SOLE 19,379,038 0 0
CHIME COM SHS CL A 16935C109 435,398,308 21,259,683 SH SOLE 21,259,683 0 0
DLOCAL CL A G29018101 606,303,752 46,656,695 SH SOLE 46,656,695 0 0
GROVE COLLABORATIVE CL A 39957D201 3,093,574 2,474,859 SH SOLE 2,474,859 0 0
LIFTOFF MOBILE COM 53229X101 608,081,817 25,315,646 SH SOLE 25,315,646 0 0
NURIX THERAPEUTICS COM 67080M103 73,560,808 3,032,185 SH SOLE 3,032,185 0 0
PARABILIS MEDICINES COM 698955101 42,107,678 1,538,461 SH SOLE 1,538,461 0 0
PHARVARIS COM N69605108 226,525,177 6,550,757 SH SOLE 6,550,757 0 0
REVOLUTION MEDICINES COM 76155X100 67,007,098 357,791 SH SOLE 357,791 0 0
RISKIFIED CL A M8216R109 26,837,990 5,324,998 SH SOLE 5,324,998 0 0
SEAPORT THERAPEUTICS COM 81221K108 132,526,361 6,101,582 SH SOLE 6,101,582 0 0
XP, INC CL A G98239109 334,405,323 20,566,133 SH SOLE 20,566,133 0 0